Comment on 'Active surveillance for intermediate risk prostate cancer: the Manitoba Prostate Center experience'

Yang Xu1, Dejun Hu1, Yuanfeng Ruan1

  • 1Department of Urology, XuanCheng City Central Hospital, Xuancheng, China.

BJU International
|July 10, 2026
PubMed
Abstract

No abstract available in PubMed .